{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:12:30Z","timestamp":1790208750828,"version":"4.1.0"},"reference-count":172,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Chronic inflammatory diseases, such as rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, Crohn\u2019s disease, periodontitis, and carcinoma metastasis frequently result in bone destruction. Pro-inflammatory cytokines such as tumor necrosis factor-\u03b1 (TNF-\u03b1), interleukin-1\u03b2 (IL-1\u03b2), IL-6, and IL-17 are known to influence bone loss by promoting the differentiation and activation of osteoclasts. Fibrinolytic factors, such as plasminogen (Plg), plasmin, urokinase-type plasminogen activator (uPA), its receptor (uPAR), tissue-type plasminogen activator (tPA), \u03b12-antiplasmin (\u03b12AP), and plasminogen activator inhibitor-1 (PAI-1) are expressed in osteoclasts and osteoblasts and are considered essential in maintaining bone homeostasis by regulating the functions of both osteoclasts and osteoblasts. Additionally, fibrinolytic factors are associated with the regulation of inflammation and the immune system. This review explores the roles of fibrinolytic factors in bone destruction caused by inflammation.<\/jats:p>","DOI":"10.3390\/cells13060516","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T12:02:39Z","timestamp":1710504159000},"page":"516","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The Roles of Fibrinolytic Factors in Bone Destruction Caused by Inflammation"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9741-2113","authenticated-orcid":false,"given":"Yosuke","family":"Kanno","sequence":"first","affiliation":[{"name":"Department of Molecular Pathology, Faculty of Pharmaceutical Science, Doshisha Women\u2019s College of Liberal Arts, 97-1 Kodo Kyotanabe, Kyoto 610-0395, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Terkawi, M., Matsumae, G., Shimizu, T., Takahashi, D., Kadoya, K., and Iwasaki, N. (2022). Interplay between Inflammation and Pathological Bone Resorption: Insights into Recent Mechanisms and Pathways in Related Diseases for Future Perspectives. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031786"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"116540","DOI":"10.1016\/j.bone.2022.116540","article-title":"Cytokine-mediated immunomodulation of osteoclastogenesis","volume":"164","author":"Zhou","year":"2022","journal-title":"Bone"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"511799","DOI":"10.3389\/fphys.2020.511799","article-title":"The Effect of Inflammation on Bone","volume":"11","author":"Epsley","year":"2021","journal-title":"Front. Physiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2174\/1568010054022015","article-title":"Osteoblasts and osteoclasts in bone remodeling and inflammation","volume":"4","author":"Tanaka","year":"2005","journal-title":"Curr. Drug Targets Inflamm. Allergy"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Kanno, Y. (2019). The Role of Fibrinolytic Regulators in Vascular Dysfunction of Systemic Sclerosis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20030619"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1016\/j.jtha.2023.07.013","article-title":"Crosstalk between the plasminogen\/plasmin system and inflammation resolution","volume":"21","author":"Perucci","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Kanno, Y. (2023). The uPA\/uPAR System Orchestrates the Inflammatory Response, Vascular Homeostasis, and Immune System in Fibrosis Progression. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021796"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1212201","DOI":"10.3389\/fmed.2023.1212201","article-title":"All tangled up: Interactions of the fibrinolytic and innate immune systems","volume":"10","author":"Whyte","year":"2023","journal-title":"Front. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s41232-020-00128-5","article-title":"Roles of fibrinolytic factors in the alterations in bone marrow hematopoietic stem\/progenitor cells during bone repair","volume":"40","author":"Okada","year":"2020","journal-title":"Inflamm. Regen."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Ribet, A., Ng, P., and Pavlos, N. (2021). Membrane Transport Proteins in Osteoclasts: The Ins and Outs. Front. Cell Dev. Biol., 26.","DOI":"10.3389\/fcell.2021.644986"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41577-019-0178-8","article-title":"Osteoimmunology: Evolving concepts in bone-immune interactions in health and disease","volume":"19","author":"Tsukasaki","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nrrheum.2017.213","article-title":"Updating osteoimmunology: Regulation of bone cells by innate and adaptive immunity","volume":"14","author":"Walsh","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.4110\/in.2018.18.e8","article-title":"Regulation of Osteoclast Differentiation by Cytokine Networks","volume":"18","author":"Amarasekara","year":"2018","journal-title":"Immune Netw."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11914-017-0358-z","article-title":"TNF and Bone Remodeling","volume":"15","author":"Zhao","year":"2017","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.4049\/jimmunol.0803007","article-title":"The mechanism of osteoclast differentiation induced by IL-1","volume":"183","author":"Kim","year":"2009","journal-title":"J. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"11395","DOI":"10.1074\/jbc.M411189200","article-title":"Prostaglandin E2 enhances osteoclastic differentiation of precursor cells through protein kinase A-dependent phosphorylation of TAK1","volume":"280","author":"Kobayashi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.7150\/ijbs.72211","article-title":"Knockout and Double Knockout of Cathepsin K and Mmp9 reveals a novel function of Cathepsin K as a regulator of osteoclast gene expression and bone homeostasis","volume":"18","author":"Zhu","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"R105","DOI":"10.1186\/bcr3047","article-title":"MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases","volume":"13","author":"Pivetta","year":"2011","journal-title":"Breast Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jobcr.2023.06.002","article-title":"Role of matrix metalloproteinases in bone regeneration: Narrative review","volume":"13","author":"Khoswanto","year":"2023","journal-title":"J. Oral Biol. Craniofac. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"917","DOI":"10.4049\/jimmunol.175.2.917","article-title":"IL-4 inhibits bone-resorbing activity of mature osteoclasts by affecting NF-\u03baB and Ca2+ signaling","volume":"175","author":"Mangashetti","year":"2005","journal-title":"J. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Evans, K., and Fox, S. (2007). Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus. BMC Cell Biol., 8.","DOI":"10.1186\/1471-2121-8-4"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/jbmr.350","article-title":"Interferon-\u03b3 plays a role in bone formation in vivo and rescues osteoporosis in ovariectomized mice","volume":"26","author":"Duque","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1172\/JCI11232","article-title":"Expression of IL-5 alters bone metabolism and induces ossification of the spleen in transgenic mice","volume":"107","author":"Macias","year":"2001","journal-title":"J. Clin. Investig."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1007\/s11033-021-06288-y","article-title":"Osteoblast role in the pathogenesis of rheumatoid arthritis","volume":"48","author":"Berardi","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Kim, J., Lin, C., Stavre, Z., Greenblatt, M., and Shim, J. (2020). Osteoblast-Osteoclast Communication and Bone Homeostasis. Cells, 9.","DOI":"10.3390\/cells9092073"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature07713","article-title":"Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis","volume":"458","author":"Ishii","year":"2009","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1172\/JCI69493","article-title":"Osteoclast-secreted CTHRC1 in the coupling of bone resorption to formation","volume":"123","author":"Takeshita","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/jbmr.2187","article-title":"Osteoclast-derived complement component 3a stimulates osteoblast differentiation","volume":"29","author":"Matsuoka","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm.2499","article-title":"Targeting osteoclast-osteoblast communication","volume":"17","author":"Cao","year":"2011","journal-title":"Nat. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41419-020-03059-8","article-title":"Osteocyte apoptosis: The roles and key molecular mechanisms in resorption-related bone diseases","volume":"11","author":"Ru","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00281-011-0290-8","article-title":"Fibrinogen as a key regulator of inflammation in disease","volume":"34","author":"Davalos","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"109761","DOI":"10.1016\/j.cellsig.2020.109761","article-title":"The multifaceted role of plasminogen in inflammation","volume":"75","author":"Heissig","year":"2020","journal-title":"Cell Signal"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1136\/annrheumdis-2012-201906","article-title":"Citrullination enhances the pro-inflammatory response to fibrin in rheumatoid arthritis synovial fibroblasts","volume":"72","author":"Filkova","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood-2018-07-818211","article-title":"The multifaceted role of fibrinogen in tissue injury and inflammation","volume":"133","author":"Luyendyk","year":"2019","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/art.38639","article-title":"Fibrin accumulation secondary to loss of plasmin-mediated fibrinolysis drives inflammatory osteoporosis in mice","volume":"66","author":"Cole","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"ref_37","first-page":"e28647","article-title":"Injectable Platelet-Rich Fibrin\u2014A Revolution in Periodontal Regeneration","volume":"14","author":"Gollapudi","year":"2022","journal-title":"Cureus"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/art.1780350806","article-title":"Analysis of intraarticular fibrinolytic pathways in patients with inflammatory and noninflammatory joint diseases","volume":"35","author":"Kummer","year":"1992","journal-title":"Arthritis Rheum."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"970","DOI":"10.2174\/1389450120666181204164140","article-title":"The Urokinase Plasminogen Activation System in Rheumatoid Arthritis: Pathophysiological Roles and Prospective Therapeutic Targets","volume":"20","author":"Buckley","year":"2019","journal-title":"Curr. Drug Targets"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.58.8.488","article-title":"Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: Increased concentrations in rheumatoid arthritis","volume":"58","author":"Slot","year":"1999","journal-title":"Ann. Rheum. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"16903","DOI":"10.1038\/s41598-021-96349-w","article-title":"Plasma fibrinogen, D-dimer, and fibrin degradation product as biomarkers of rheumatoid arthritis","volume":"11","author":"Xue","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1160\/TH05-05-0310","article-title":"Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state","volume":"95","author":"Pereira","year":"2006","journal-title":"Thromb. Haemost."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1191\/096120399678840918","article-title":"Clinical significance of hemostatic markers and thrombomodulin in systemic lupus erythematosus: Evidence for a prothrombotic state","volume":"8","author":"Kiraz","year":"1999","journal-title":"Lupus"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/MBC.0000000000000504","article-title":"Changes to fibrinolysis in patients with systemic lupus erythematosus are associated with endothelial cell damage and inflammation, but not antiphospholipid antibodies","volume":"27","author":"Dhillon","year":"2016","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/1354750X.2021.1910343","article-title":"Urine soluble urokinase plasminogen activator receptor as a potential biomarker of lupus nephritis activity","volume":"26","author":"Toldi","year":"2021","journal-title":"Biomarkers"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3109\/1354750X.2012.728623","article-title":"Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in systemic lupus erythematosus","volume":"17","author":"Toldi","year":"2012","journal-title":"Biomarkers"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/art.24603","article-title":"Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus","volume":"60","author":"Trysberg","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/MBC.0000000000001247","article-title":"Reduced ADAMTS13 activity and high D-dimer levels are associated with thrombosis in patients with systemic lupus erythematosus","volume":"34","author":"Penglong","year":"2023","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3892\/etm.2022.11531","article-title":"Decreased low-density lipoprotein and the presence of pulmonary arterial hypertension among newly diagnosed drug-na\u00efve patients with systemic lupus erythematosus: D-dimer as a mediator","volume":"24","author":"Huang","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000073850","article-title":"Coagulation and fibrinolysis in inflammatory bowel disease and in giant cell arteritis","volume":"33","author":"Vrij","year":"2003","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3109\/00365521.2012.699549","article-title":"Soluble urokinase plasminogen activator receptor suPAR as a marker for inflammation in pediatric inflammatory bowel disease","volume":"47","author":"Kolho","year":"2012","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1096\/fasebj.13.13.1774","article-title":"Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: Down-regulation by cAMP","volume":"13","author":"Duncan","year":"1999","journal-title":"FASEB J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"213","DOI":"10.15403\/jgld-183","article-title":"Assessment of Crohn\u2019s Disease Activity: Magnetic Resonance Enterography in Comparison with Clinical and Endoscopic Evaluations","volume":"28","author":"Minordi","year":"2019","journal-title":"J. Gastrointestin Liver Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/jre.12748","article-title":"Assessment of saliva and gingival crevicular fluid soluble urokinase plasminogen activator receptor (suPAR), galectin-1, and TNF-\u03b1 levels in periodontal health and disease","volume":"55","author":"Narin","year":"2020","journal-title":"J. Periodontal Res."},{"key":"ref_55","first-page":"165","article-title":"Content of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in oral mucosa and inflamed periodontal tissue","volume":"41","author":"Deppe","year":"2010","journal-title":"Quintessence Int."},{"key":"ref_56","first-page":"ZC10","article-title":"Fibrinogen Degradation Products and Periodontitis: Deciphering the Connection","volume":"9","author":"Dikshit","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1189\/jlb.0212056","article-title":"Plasmin as a proinflammatory cell activator","volume":"92","author":"Syrovets","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/jth.12064","article-title":"Plasminogen receptors and their role in the pathogenesis of inflammatory, autoimmune and malignant disease","volume":"11","author":"Godier","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Ismail, A., Shaker, B., and Bajou, K. (2021). The Plasminogen-Activator Plasmin System in Physiological and Pathophysiological Angiogenesis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010337"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-0036-1586227","article-title":"Plasmin: A Modulator of Immune Function","volume":"43","author":"Draxler","year":"2017","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.sbi.2013.10.006","article-title":"New insights into the structure and function of the plasminogen\/plasmin system","volume":"23","author":"Law","year":"2013","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"27633","DOI":"10.1074\/jbc.M313617200","article-title":"Collagenolysis-dependent angiogenesis mediated by matrix metalloproteinase-13 (collagenase-3)","volume":"279","author":"Zijlstra","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"8952","DOI":"10.1074\/jbc.M110.152181","article-title":"Plasminogen\/plasmin modulates bone metabolism by regulating the osteoblast and osteoclast function","volume":"286","author":"Kanno","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/jbmr.1921","article-title":"Plasminogen plays a crucial role in bone repair","volume":"28","author":"Kawao","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Kawao, N., Tamura, Y., Horiuchi, Y., Okumoto, K., Yano, M., Okada, K., Matsuo, O., and Kaji, H. (2015). The Tissue Fibrinolytic System Contributes to the Induction of Macrophage Function and CCL3 during Bone Repair in Mice. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0123982"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"63","DOI":"10.7150\/ijbs.12690","article-title":"uPA Attenuated LPS-induced Inflammatory Osteoclastogenesis through the Plasmin\/PAR-1\/Ca2+\/CaMKK\/AMPK Axis","volume":"12","author":"Kanno","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1182\/blood-2016-09-742825","article-title":"Plasmin and plasminogen induce macrophage reprogramming and regulate key steps of inflammation resolution via annexin A1","volume":"129","author":"Sugimoto","year":"2017","journal-title":"Blood"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Jann, J., Gascon, S., Roux, S., and Faucheux, N. (2020). Influence of the TGF-\u03b2 Superfamily on Osteoclasts\/Osteoblasts Balance in Physiological and Pathological Bone Conditions. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207597"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cytogfr.2013.03.008","article-title":"Angiogenic factors in bone local environment","volume":"24","author":"Chim","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3389\/fimmu.2019.01458","article-title":"Plasminogen and the Plasminogen Receptor, Plg-RKT, Regulate Macrophage Phenotypic, and Functional Changes","volume":"10","author":"Vago","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41419-020-2397-0","article-title":"Plasminogen is a master regulator and a potential drug candidate for the healing of radiation wounds","volume":"11","author":"Fallah","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1182\/blood.V97.12.3941","article-title":"Plasmin-induced expression of cytokines and tissue factor in human monocytes involves AP-1 and IKK\u03b2-mediated NF-\u03baB activation","volume":"97","author":"Syrovets","year":"2001","journal-title":"Blood"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/ATVBAHA.109.202044","article-title":"Plasmin triggers chemotaxis of monocyte-derived dendritic cells through an Akt2-dependent pathway and promotes a T-helper type-1 response","volume":"30","author":"Li","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12959-023-00540-0","article-title":"Tranexamic acid for haemostasis and beyond: Does dose matter?","volume":"21","author":"Lam","year":"2023","journal-title":"Thromb. J."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Baranowsky, A., Appelt, J., Tseneva, K., Jiang, S., Jahn, D., Tsitsilonis, S., Frosch, K., and Keller, J. (2021). Tranexamic Acid Promotes Murine Bone Marrow-Derived Osteoblast Proliferation and Inhibits Osteoclast Formation In Vitro. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010449"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.4049\/jimmunol.1400334","article-title":"Plasmin induces in vivo monocyte recruitment through protease-activated receptor-1-, MEK\/ERK-, and CCR2-mediated signaling","volume":"193","author":"Carmo","year":"2014","journal-title":"J. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bone.2015.10.005","article-title":"Thrombin induced by the extrinsic pathway and PAR-1 regulated inflammation at the site of fracture repair","volume":"83","author":"Sato","year":"2016","journal-title":"Bone"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"26031","DOI":"10.1016\/S0021-9258(18)35712-0","article-title":"Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms","volume":"267","author":"Houck","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cbf.2911","article-title":"VEGF and bone cell signalling: An essential vessel for communication?","volume":"31","author":"Clarkin","year":"2013","journal-title":"Cell Biochem. Funct."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"32628","DOI":"10.1074\/jbc.M114.567792","article-title":"Plasminogen kringle 5 induces endothelial cell apoptosis by triggering a voltage-dependent anion channel 1 (VDAC1) positive feedback loop","volume":"289","author":"Li","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/156652413804486214","article-title":"Functions of S100 proteins","volume":"13","author":"Donato","year":"2013","journal-title":"Curr. Mol. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1182\/blood-2009-06-226944","article-title":"Annexin A2 tetramer activates human and murine macrophages through TLR4","volume":"115","author":"Swisher","year":"2010","journal-title":"Blood"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/s41423-019-0278-1","article-title":"Essential roles of S100A10 in Toll-like receptor signaling and immunity to infection","volume":"17","author":"Lou","year":"2020","journal-title":"Cell Mol. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1158\/1535-7163.MCT-21-0285","article-title":"A Novel Enolase-1 Antibody Targets Multiple Interacting Players in the Tumor Microenvironment of Advanced Prostate Cancer","volume":"21","author":"Chen","year":"2022","journal-title":"Mol. Cancer Ther."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"45826","DOI":"10.1074\/jbc.M309024200","article-title":"Angiostatin inhibits bone metastasis formation in nude mice through a direct anti-osteoclastic activity","volume":"278","author":"Peyruchaud","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.it.2004.06.004","article-title":"uPA and uPAR in fibrinolysis, immunity and pathology","volume":"25","author":"Mondino","year":"2004","journal-title":"Trends Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1160\/TH06-11-0669","article-title":"uPAR-uPA-PAI-1 interactions and signaling: A vascular biologist\u2019s view","volume":"97","author":"Binder","year":"2007","journal-title":"Thromb. Haemost."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Napolitano, F., and Montuori, N. (2021). The Role of the Plasminogen Activation System in Angioedema: Novel Insights on the Pathogenesis. J. Clin. Med., 10.","DOI":"10.3390\/jcm10030518"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.2174\/138161211796718189","article-title":"The urokinase receptor system, a key regulator at the intersection between inflammation, immunity, and coagulation","volume":"17","author":"Margheri","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1038\/jid.2008.157","article-title":"The absence of uPAR is associated with the progression of dermal fibrosis","volume":"128","author":"Kanno","year":"2008","journal-title":"J. Investig. Dermatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrm977","article-title":"uPAR: A versatile signalling orchestrator","volume":"3","author":"Blasi","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1160\/TH10-02-0101","article-title":"Urokinase-type plasminogen activator receptor is associated with the development of adipose tissue","volume":"104","author":"Kanno","year":"2010","journal-title":"Thromb. Haemost."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Medcalf, R., and Keragala, C. (2021). Fibrinolysis: A Primordial System Linked to the Immune Response. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073406"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Hastings, S., Myles, P., and Medcalf, R. (2021). Plasmin, Immunity, and Surgical Site Infection. J. Clin. Med., 10.","DOI":"10.3390\/jcm10102070"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Liu, G., Yang, Y., Yang, S., Banerjee, S., De Freitas, A., Friggeri, A., Davis, K., and Abraham, E. (2011). The receptor for urokinase regulates TLR2 mediated inflammatory responses in neutrophils. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0025843"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.molimm.2020.08.018","article-title":"Urokinase-type plasminogen activator receptor is required for impairing toll-like receptor 7 signaling on macrophage efferocytosis in lupus","volume":"127","author":"Li","year":"2020","journal-title":"Mol. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"573550","DOI":"10.3389\/fimmu.2020.573550","article-title":"TLR4 Response to LPS Is Reinforced by Urokinase Receptor","volume":"11","author":"Kiyan","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"780641","DOI":"10.3389\/fimmu.2021.780641","article-title":"Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation","volume":"12","author":"Rasmussen","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Alfano, D., Franco, P., and Stoppelli, M. (2022). Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.818616"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1359\/jbmr.2003.18.7.1167","article-title":"Increased bone formation in mice lacking plasminogen activators","volume":"18","author":"Daci","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.bone.2008.07.004","article-title":"Plasminogen activators are involved in the degradation of bone by osteoclasts","volume":"43","author":"Everts","year":"2008","journal-title":"Bone"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"6941368","DOI":"10.1155\/2018\/6941368","article-title":"Urokinase Attenuates Pulmonary Thromboembolism in an Animal Model by Inhibition of Inflammatory Response","volume":"2018","author":"Shi","year":"2018","journal-title":"J. Immunol. Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1359\/jbmr.070516","article-title":"Urokinase plasminogen activator receptor affects bone homeostasis by regulating osteoblast and osteoclast function","volume":"22","author":"Furlan","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/jbmr.2350","article-title":"Urokinase receptor mediates osteoclastogenesis via M-CSF release from osteoblasts and the c-Fms\/PI3K\/Akt\/NF-\u03baB pathway in osteoclasts","volume":"30","author":"Patecki","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/iid3.116","article-title":"The blocking of uPAR suppresses lipopolysaccharide-induced inflammatory osteoclastogenesis and the resultant bone loss through attenuation of integrin \u03b23\/Akt pathway","volume":"4","author":"Kanno","year":"2016","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/iid3.169","article-title":"uPA-derived peptide, \u00c56 is involved in the suppression of lipopolysaccaride-promoted inflammatory osteoclastogenesis and the resultant bone loss","volume":"5","author":"Kanno","year":"2017","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1096\/fasebj.14.10.1400","article-title":"A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo","volume":"14","author":"Guo","year":"2000","journal-title":"FASEB J."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/jbmr.2115","article-title":"Compressive force-produced CCN2 induces osteocyte apoptosis through ERK1\/2 pathway","volume":"29","author":"Hoshi","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jcp.24734","article-title":"VEGF Receptor 2 (VEGFR2) Activation Is Essential for Osteocyte Survival Induced by Mechanotransduction","volume":"230","author":"Maycas","year":"2015","journal-title":"J. Cell Physiol."},{"key":"ref_110","first-page":"415","article-title":"Impacts of tissue-type plasminogen activator (tPA) on neuronal survival","volume":"16","author":"Chevilley","year":"2015","journal-title":"Front. Cell Neurosci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1038\/sj.emboj.7600397","article-title":"Tissue plasminogen activator is a potent activator of PDGF-CC","volume":"23","author":"Fredriksson","year":"2004","journal-title":"EMBO J."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/jcbfm.2008.14","article-title":"Toward safer thrombolytic agents in stroke: Molecular requirements for NMDA receptor-mediated neurotoxicity","volume":"28","author":"Roussel","year":"2008","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"E278","DOI":"10.1152\/ajpendo.00129.2014","article-title":"Tissue-type plasminogen activator deficiency delays bone repair: Roles of osteoblastic proliferation and vascular endothelial growth factor","volume":"307","author":"Kawao","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.mvr.2014.07.009","article-title":"IGFBP-3 inhibits TNF-\u03b1 production and TNFR-2 signaling to protect against retinal endothelial cell apoptosis","volume":"95","author":"Zhang","year":"2014","journal-title":"Microvasc. Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1182\/blood-2017-04-780205","article-title":"Tissue-type plasminogen activator regulates macrophage activation and innate immunity","volume":"130","author":"Mantuano","year":"2017","journal-title":"Blood"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/JLB.3A0818-329RRR","article-title":"Tissue-type plasminogen activator neutralizes LPS but not protease-activated receptor-mediated inflammatory responses to plasmin","volume":"105","author":"Zalfa","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.job.2020.03.003","article-title":"Effects of N-methyl-d-aspartate receptor antagonist MK-801 (dizocilpine) on bone homeostasis in mice","volume":"62","author":"Kiyohara","year":"2020","journal-title":"J. Oral. Biosci."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neuroscience.2021.01.003","article-title":"Matrix Metalloproteinase-9 Expression is Enhanced by Ischemia and Tissue Plasminogen Activator and Induces Hemorrhage, Disability and Mortality in Experimental Stroke","volume":"460","author":"Saleem","year":"2021","journal-title":"Neuroscience"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1432-1033.1994.tb20005.x","article-title":"Characterization of the interaction between plasminogen and staphylokinase","volume":"224","author":"Lijnen","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/anr.1780321112","article-title":"Elevated plasma levels of \u03b12-plasmin inhibitor-plasmin complex in patients with rheumatic diseases. Possible role of fibrinolytic mechanism in vasculitis","volume":"32","author":"Kawakami","year":"1989","journal-title":"Arthritis Rheum."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0891-6632(90)90018-Z","article-title":"Fibrinolysis in patients with diabetic nephropathy determined by plasmin-\u03b12 plasmin inhibitor complexes in plasma","volume":"4","author":"Yagame","year":"1990","journal-title":"J. Diabet. Complicat."},{"key":"ref_122","first-page":"77","article-title":"The effects of alpha 2-antiplasmin complex and \u03b12-antiplasmin on the secretion of IgG and IgM by cultured human mononuclear cells","volume":"49","author":"Zhabin","year":"1997","journal-title":"J. Clin. Lab. Immunol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1182\/blood-2015-09-670117","article-title":"Natural heterogeneity of \u03b12-antiplasmin: Functional and clinical consequences","volume":"127","author":"Abdul","year":"2016","journal-title":"Blood"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1182\/blood-2005-08-3452","article-title":"Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein","volume":"107","author":"Lee","year":"2006","journal-title":"Blood"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.abb.2006.11.006","article-title":"Effect of fibroblast activation protein and \u03b12-antiplasmin cleaving enzyme on collagen types I, III, and IV","volume":"457","author":"Christiansen","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1182\/blood-2007-09-114215","article-title":"X-ray crystal structure of the fibrinolysis inhibitor \u03b12-antiplasmin","volume":"111","author":"Law","year":"2008","journal-title":"Blood"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jsb.2005.05.005","article-title":"PEDF and the serpins: Phylogeny, sequence conservation, and functional domains","volume":"151","author":"Aparicio","year":"2005","journal-title":"J. Struct. Biol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/art.37767","article-title":"Alpha2-antiplasmin regulates the development of dermal fibrosis in mice by prostaglandin F(2\u03b1) synthesis through adipose triglyceride lipase\/calcium-independent phospholipase A2","volume":"65","author":"Kanno","year":"2013","journal-title":"Arthritis Rheum."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11033-021-06859-z","article-title":"\u03b12-antiplasmin positively regulates endothelial-to-mesenchymal transition and fibrosis progression in diabetic nephropathy","volume":"49","author":"Kanno","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2353\/ajpath.2010.090150","article-title":"\u03b12-antiplasmin is associated with the progression of fibrosis","volume":"176","author":"Kanno","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13075-020-02159-2","article-title":"Alternatively activated macrophages are associated with the \u03b12AP production that occurs with the development of dermal fibrosis: The role of alternatively activated macrophages on the development of fibrosis","volume":"22","author":"Kanno","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1111\/j.1538-7836.2006.01978.x","article-title":"Lack of alpha2-antiplasmin improves cutaneous wound healing via over-released vascular endothelial growth factor-induced angiogenesis in wound lesions","volume":"4","author":"Kanno","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jid.2015.12.028","article-title":"The Antifibrotic Effect of \u03b12AP Neutralization in Systemic Sclerosis Dermal Fibroblasts and Mouse Models of Systemic Sclerosis","volume":"136","author":"Kanno","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/iid3.302","article-title":"\u03b12AP is associated with the development of lupus nephritis through the regulation of plasmin inhibition and inflammatory responses","volume":"8","author":"Kanno","year":"2020","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13075-017-1227-y","article-title":"\u03b12AP regulates vascular alteration by inhibiting VEGF signaling in systemic sclerosis: The roles of \u03b12AP in vascular dysfunction in systemic sclerosis","volume":"19","author":"Kanno","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1172\/JCI118694","article-title":"The kidney is a major site of \u03b12-antiplasmin production","volume":"97","author":"Menoud","year":"1996","journal-title":"J. Clin. Investig."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3892\/ijmm.2017.3055","article-title":"\u03b12-antiplasmin modulates bone formation by negatively regulating osteoblast differentiation and function","volume":"40","author":"Kanno","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bone.2015.06.009","article-title":"\u03b12-Antiplasmin is involved in bone loss induced by ovariectomy in mice","volume":"79","author":"Shiomi","year":"2015","journal-title":"Bone"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1096\/fj.14-260844","article-title":"SHP2 regulates osteoclastogenesis by promoting preosteoclast fusion","volume":"29","author":"Zhou","year":"2015","journal-title":"FASEB J."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1007\/s11033-021-06368-z","article-title":"MicroRNA-30c attenuates fibrosis progression and vascular dysfunction in systemic sclerosis model mice","volume":"48","author":"Kanno","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/jbmr.222","article-title":"CCN family 2\/connective tissue growth factor (CCN2\/CTGF) promotes osteoclastogenesis via induction of and interaction with dendritic cell-specific transmembrane protein (DC-STAMP)","volume":"26","author":"Nishida","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.bone.2014.12.058","article-title":"CCN2 enhances RANKL-induced osteoclast differentiation via direct binding to RANK and OPG","volume":"73","author":"Aoyama","year":"2015","journal-title":"Bone"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"16741","DOI":"10.1002\/jcb.28932","article-title":"High mobility group box 1 protein regulates osteoclastogenesis through direct actions on osteocytes and osteoclasts in vitro","volume":"120","author":"Davis","year":"2019","journal-title":"J. Cell Biochem."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.bbrc.2020.07.120","article-title":"High-mobility group box 1 induces bone destruction associated with advanced oral squamous cancer via RAGE and TLR4","volume":"531","author":"Sakamoto","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3389\/fimmu.2018.01508","article-title":"Interferon-\u03b3-Mediated Osteoimmunology","volume":"9","author":"Tang","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_146","first-page":"3001","article-title":"Decrease in matrix metalloproteinase-3 activity in systemic sclerosis fibroblasts causes \u03b12-antiplasmin and extracellular matrix deposition, and contributes to fibrosis development","volume":"22","author":"Niwa","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.1747","article-title":"ER\u03b1 signaling regulates MMP3 expression to induce FasL cleavage and osteoclast apoptosis","volume":"28","author":"Garcia","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/jbmr.1480","article-title":"Lack of expression of SERPINF1, the gene coding for pigment epithelium-derived factor, causes progressively deforming osteogenesis imperfecta with normal type I collagen","volume":"27","author":"Venturi","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/stem.1505","article-title":"Pigment epithelium-derived factor enhances differentiation and mineral deposition of human mesenchymal stem cells","volume":"31","author":"Li","year":"2013","journal-title":"Stem Cells"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1016\/j.bbadis.2018.07.034","article-title":"Pigment epithelium derived factor regulates human Sost\/Sclerostin and other osteocyte gene expression via the receptor and induction of Erk\/GSK-3\u03b2\/beta-catenin signaling","volume":"1864","author":"Li","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.bbrc.2009.11.139","article-title":"PEDF regulates osteoclasts via osteoprotegerin and RANKL","volume":"391","author":"Akiyama","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1515\/jbcpp-2021-0282","article-title":"Alpha2-antiplasmin deficiency affects depression and anxiety-like behavior and apoptosis induced by stress in mice","volume":"33","author":"Kanno","year":"2021","journal-title":"J. Basic. Clin. Physiol. Pharmacol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/ATVBAHA.117.309451","article-title":"Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of Senescence","volume":"37","author":"Vaughan","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Badran, M., and Gozal, D. (2022). PAI-1: A Major Player in the Vascular Dysfunction in Obstructive Sleep Apnea?. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105516"},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Sillen, M., and Declerck, P. (2021). A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target?. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052721"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jcb.26146","article-title":"Plasminogen Activator Inhibitor Type-1 as a Regulator of Fibrosis","volume":"119","author":"Rabieian","year":"2018","journal-title":"J. Cell Biochem."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1006\/bbrc.2000.4045","article-title":"Release of PAI-1 by human preadipocytes and adipocytes independent of insulin and IGF-1","volume":"279","author":"Crandall","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/01.CIR.97.21.2175","article-title":"Induction of plasminogen activator inhibitor type 1 and type 1 collagen expression in rat cardiac microvascular endothelial cells by interleukin-1 and its dependence on oxygen-centered free radicals","volume":"97","author":"Okada","year":"1998","journal-title":"Circulation"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1096\/fj.07-8276com","article-title":"EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCdelta, and sphingosine kinase 1 in glioblastoma cells","volume":"22","author":"Paugh","year":"2008","journal-title":"FASEB J."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"622473","DOI":"10.3389\/fcvm.2020.622473","article-title":"Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition","volume":"7","author":"Sillen","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00223-008-9169-7","article-title":"Fracture healing in mice deficient in plasminogen activator inhibitor-1","volume":"83","author":"Rundle","year":"2008","journal-title":"Calcif. Tissue Int."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.2337\/db12-1552","article-title":"Plasminogen activator inhibitor-1 is involved in streptozotocin-induced bone loss in female mice","volume":"62","author":"Tamura","year":"2013","journal-title":"Diabetes"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1359\/jbmr.2000.15.8.1510","article-title":"Mice lacking the plasminogen activator inhibitor 1 are protected from trabecular bone loss induced by estrogen deficiency","volume":"15","author":"Daci","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.2337\/db14-1192","article-title":"Role of plasminogen activator inhibitor-1 in glucocorticoid-induced diabetes and osteopenia in mice","volume":"64","author":"Tamura","year":"2015","journal-title":"Diabetes"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"L247","DOI":"10.1152\/ajplung.00075.2011","article-title":"Inhibition of neutrophil apoptosis by PAI-1","volume":"301","author":"Zmijewski","year":"2011","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1182\/blood-2011-12-399659","article-title":"Inhibition of PAI-1 induces neutrophil-driven neoangiogenesis and promotes tissue regeneration via production of angiocrine factors in mice","volume":"119","author":"Tashiro","year":"2012","journal-title":"Blood"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biocel.2014.01.008","article-title":"The LRP1-independent mechanism of PAI-1-induced migration in CpG-ODN activated macrophages","volume":"49","author":"Thapa","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"113252","DOI":"10.1016\/j.yexcr.2022.113252","article-title":"A vitronectin-derived dimeric peptide suppresses osteoclastogenesis by binding to c-Fms and inhibiting M-CSF signaling","volume":"418","author":"Jung","year":"2022","journal-title":"Exp. Cell Res."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s13770-022-00486-w","article-title":"A Vitronectin-Derived Peptide Restores Ovariectomy-Induced Bone Loss by Dual Regulation of Bone Remodeling","volume":"19","author":"Kang","year":"2022","journal-title":"Tissue Eng. Regen. Med."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"19229","DOI":"10.1074\/jbc.M111.323600","article-title":"Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion","volume":"287","author":"Okayasu","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"121073","DOI":"10.1016\/j.lfs.2022.121073","article-title":"Low-density lipoprotein receptor deficiency reduced bone mass in mice via the c-fos\/NFATc1 pathway","volume":"10","author":"Qi","year":"2022","journal-title":"Life Sci."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jacbts.2021.09.011","article-title":"Interplay of Low-Density Lipoprotein Receptors, LRPs, and Lipoproteins in Pulmonary Hypertension","volume":"7","author":"Calvier","year":"2022","journal-title":"JACC Basic Transl. Sci."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/6\/516\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:14:08Z","timestamp":1760105648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/6\/516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,15]]},"references-count":172,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["cells13060516"],"URL":"https:\/\/doi.org\/10.3390\/cells13060516","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,15]]}}}